OSUR Orasure Technologies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OSUR

Price (delayed)

$5.5

Market cap

$405.88M

P/E Ratio

7.53

Dividend/share

N/A

EPS

$0.73

Enterprise value

$128.98M

OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides ...

Highlights
The stock's price to earnings (P/E) is 32% less than its last 4 quarters average of 11.0
The quick ratio is up by 23% QoQ
The company's gross profit rose by 16% YoY but it fell by 8% QoQ
Orasure Technologies's debt has decreased by 10% QoQ but it has increased by 8% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.orasure.com
Peers: COO QDEL DGX BIO

Key stats

What are the main financial stats of OSUR
Market
Shares outstanding
73.8M
Market cap
$405.88M
Enterprise value
$128.98M
Valuations
Price to earnings (P/E)
7.53
Price to book (P/B)
0.94
Price to sales (P/S)
0.99
EV/EBIT
2.29
EV/EBITDA
1.67
EV/Sales
0.32
Earnings
Revenue
$405.47M
EBIT
$56.26M
EBITDA
$77.19M
Free cash flow
$131.28M
Per share
EPS
$0.73
Free cash flow per share
$1.79
Book value per share
$5.86
Revenue per share
$5.53
TBVPS
$6.08
Balance sheet
Total assets
$482.85M
Total liabilities
$52.17M
Debt
$13.5M
Equity
$430.67M
Working capital
$346.92M
Liquidity
Debt to equity
0.03
Current ratio
9.77
Quick ratio
8.36
Net debt/EBITDA
-3.59
Margins
EBITDA margin
19%
Gross margin
42.3%
Net margin
13.2%
Operating margin
10.7%
Efficiency
Return on assets
11.6%
Return on equity
13.2%
Return on invested capital
29%
Return on capital employed
12.7%
Return on sales
13.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OSUR stock price

How has the Orasure Technologies stock price performed over time
Intraday
-0.54%
1 week
4.76%
1 month
-12.97%
1 year
-21.2%
YTD
-32.93%
QTD
-10.57%

Financial performance

How have Orasure Technologies's revenue and profit performed over time
Revenue
$405.47M
Gross profit
$171.65M
Operating income
$43.51M
Net income
$53.66M
Gross margin
42.3%
Net margin
13.2%
Orasure Technologies's net margin has increased by 21% QoQ
The company's gross profit rose by 16% YoY but it fell by 8% QoQ
Orasure Technologies's operating income has decreased by 15% QoQ
The gross margin is up by 10% YoY and by 2.7% QoQ

Growth

What is Orasure Technologies's growth rate over time

Valuation

What is Orasure Technologies stock price valuation
OSUR P/E details
P/E
7.53
P/B
0.94
P/S
0.99
EV/EBIT
2.29
EV/EBITDA
1.67
EV/Sales
0.32
The stock's price to earnings (P/E) is 32% less than its last 4 quarters average of 11.0
OSUR's EPS is up by 11% QoQ
The P/B is 37% below the 5-year quarterly average of 1.5 and 15% below the last 4 quarters average of 1.1
The company's equity rose by 18% YoY and by 6% QoQ
OSUR's price to sales (P/S) is 63% lower than its 5-year quarterly average of 2.7
Orasure Technologies's revenue has decreased by 10% from the previous quarter but it has increased by 4.6% YoY

Efficiency

How efficient is Orasure Technologies business performance
OSUR's return on invested capital is up by 28% since the previous quarter
OSUR's ROS is up by 23% QoQ
The ROA has grown by 6% from the previous quarter
The return on equity has increased by 3.9% since the previous quarter

Dividends

What is OSUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OSUR.

Financial health

How did Orasure Technologies financials performed over time
Orasure Technologies's current ratio has surged by 107% YoY and by 12% QoQ
OSUR's total liabilities is down by 35% YoY and by 2.6% QoQ
Orasure Technologies's debt is 97% lower than its equity
The debt to equity has contracted by 25% from the previous quarter
The company's equity rose by 18% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.